Search
06/05/2022
Patients With Myeloproliferative Neoplasms Harbor High Frequencies of CD8 T Cell-Platelet Aggregates Associated With T Cell Suppression
Simoes, AM, Holmstrom, MO, Aehnlich, P, Rahbech, A, Radziwon-Balicka, A, Zamora, C, Klausen, TW, Skov, V, Kjaer, L, Ellervik, C, El Fassi, D, Vidal, S, Hasselbalch, HC, Andersen, MH, Straten, PT. Patients With Myeloproliferative Neoplasms Harbor High Frequencies of CD8 T Cell-Platelet Aggregates Associated With T Cell Suppression. Frontiers in Immunology. 2022; 13DOI:10.3389/fimmu.2022.866610. PMID:35603202. IF:7.300(Q1/3D).
05/05/2022
Serum cotinine cut-points for secondhand smoke exposure assessment in children under 5 years: A systemic review
Mourino N., Ruano-Raviña A., Varela Lema L., Fernández E., López M.J., Santiago-Pérez M.I., Rey-Brandariz J., Giraldo-Osorio A., Pérez-Ríos M.. Serum cotinine cut-points for secondhand smoke exposure assessment in children under 5 years: A systemic review. PLoS One. 2022; 17(5)DOI:10.1371/journal.pone.0267319. PMID:35511766. IF:3.700(Q2/4D).
05/05/2022
Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)
Rossello, X, Raposeiras-Roubin, S, Latini, R, Dominguez-Rodriguez, A, Barrabes, JA, Sanchez, PL, Anguita, M, Fernandez-Vazquez, F, Pascual-Figal, D, Hernandez, JMD, Ferraro, S, Vetrano, A, Perez-Rivera, JA, Prada-Delgado, O, Escalera, N, Staszewsky, L, Pizarro, G, Aguero, J, Pocock, S, Ottani, F, Fuster, V, Ibanez, B, SIONIS, ALESSANDRO, REBOOT-CNIC investigators. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT). European Heart Journal-Cardiovascular Pharmacotherapy. 2022; 8(3)DOI:10.1093/ehjcvp/pvab060. PMID:34351426. IF:7.100(Q1/1D).
05/05/2022
A resilient type of familial hypercholesterolaemia: case-control follow-up of genetically characterized older patients in the SAFEHEART cohort
Pérez de Isla L, Watts GF, Muñiz-Grijalvo O, Díaz-Díaz JL, Alonso R, Zambón D, Fuentes-Jimenez F, Mauri M, Padró T, Vidal-Pardo JI, Barba MA, Ruiz-Pérez E, Michán A, Mediavilla JD, Hernandez AM, Romero-Jimenez MJ, Badimon L, Mata P. A resilient type of familial hypercholesterolaemia: case-control follow-up of genetically characterized older patients in the SAFEHEART cohort. European Journal of Preventive Cardiology. 2022; 29(5)DOI:10.1093/eurjpc/zwab185. PMID:34864959. IF:8.300(Q1/2D).
04/05/2022
Vortioxetine in major depressive disorder: from mechanisms of action to clinical studies. An updated review
De Diego-Adelino, J, Crespo, JM, Mora, F, Neyra, A, Iborra, P, Gutierrez-Rojas, L, Salonia, SF. Vortioxetine in major depressive disorder: from mechanisms of action to clinical studies. An updated review. Expert Opinion On Drug Safety. 2022; 21(5)DOI:10.1080/14740338.2022.2019705. PMID:34964415. IF:3.100(Q3/6D).
03/05/2022
3D Imaging Segmentation and 3D Rendering Process for a Precise Puncture Strategy During PCNL - a Pilot Study
Durutovic, O, Filipovic, A, Milicevic, K, Somani, B, Emiliani, E, Skolarikos, A, Jankovic, MM. 3D Imaging Segmentation and 3D Rendering Process for a Precise Puncture Strategy During PCNL - a Pilot Study. Frontiers in Surgery. 2022; 9DOI:10.3389/fsurg.2022.891596. PMID:35592119. IF:1.800(Q3/7D).